Results 201 to 210 of about 4,900 (222)

Niosomes and discomes for ocular delivery of naltrexone hydrochloride: Morphological, rheological, spreading properties and photo-protective effects

, 2012
Hamdy Abdelkader, Zimei Wu, Raida Al‐Kassas, Raid G. Alany   +3 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss

Pharmacological Research, 2014
Puspha Sinnayah, Michael A Cowley
exaly  

Naltrexone in the Treatment of Alcohol Dependence

New England Journal of Medicine, 2001
John H Krystal, Joyce A Cramer
exaly  

Development of in vitro-in vivo correlation of parenteral naltrexone loaded polymeric microspheres

Journal of Controlled Release, 2017
Jie Shen, Yuan Zou
exaly  

Extended‐release injectable naltrexone for opioid use disorder: a systematic review

Addiction, 2018
Brantley P Jarvis, August F Holtyn, Shrinidhi Subramaniam   +2 more
exaly  

Novel in situ gelling ocular films for the opioid growth factor-receptor antagonist-naltrexone hydrochloride: Fabrication, mechanical properties, mucoadhesion, tolerability and stability studies

, 2014
Hamdy Abdelkader, Barbara Pierścionek, Raid G. Alany   +2 more
openalex   +1 more source

Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine

American Journal of Psychiatry, 2017
Maria A Sullivan, Adam Bisaga, Martina Pavlicova   +2 more
exaly  

Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta‐analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate

Addiction, 2018
Clément Palpacuer, Clara Locher, Florian Naudet   +2 more
exaly  

Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort

Drug and Alcohol Dependence, 2019
Jake R Morgan, Bruce R Schackman, Zoe M Weinstein   +2 more
exaly  

A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder

American Journal of Psychiatry, 2019
Maria A Sullivan, , Martina Pavlicova
exaly